findmyKOL
Clinical trialNCT03051256CompletedPhase 2Interventional

Safety, Tolerability, PK Profile, and Symptom Response of a 7-Day Dosing With 25 mg or 50 mg Daily of REL-1017 in MDD

SponsorRelmada Therapeutics, Inc.Enrollment62Depressive Disorder, MajorDepressive Disorder, Treatment-Resistant
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Woodland International Research Group

    Little Rock, Arkansas, United States

  • Collaborative Neuroscience Network, Llc

    Garden Grove, California, United States

  • Artemis Institute for Clinical Research

    San Diego, California, United States

  • Innovative Clinical Research, Inc

    Hialeah, Florida, United States

  • Atlanta Center for Medical Research

    Atlanta, Georgia, United States

  • Iresearch Atlanta, Llc

    Decatur, Georgia, United States

  • St. Louis Clinical Trials, Llc

    St Louis, Missouri, United States

  • Hassman Research Institute

    Berlin, New Jersey, United States

  • Midwest Clinical Research Center

    Dayton, Ohio, United States

  • Pillar Clinical Research, Llc

    Richardson, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
11 May 2018
Primary completion
30 Jul 2019
Completion
30 Sept 2019
Last update posted
1 Nov 2023
Registered enrollment
62
Registry id
NCT03051256

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.